629 related articles for article (PubMed ID: 34584404)
1. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
2. A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEX.
Zhong J; Liu D; Yang Q; Ding J; Chen X
Drug Des Devel Ther; 2024; 18():859-870. PubMed ID: 38524880
[TBL] [Abstract][Full Text] [Related]
3. Selection and targeting of EpCAM protein by ssDNA aptamer.
Alshaer W; Ababneh N; Hatmal M; Izmirli H; Choukeife M; Shraim A; Sharar N; Abu-Shiekah A; Odeh F; Al Bawab A; Awidi A; Ismail S
PLoS One; 2017; 12(12):e0189558. PubMed ID: 29245156
[TBL] [Abstract][Full Text] [Related]
4. Identification of DNA aptamers toward epithelial cell adhesion molecule via cell-SELEX.
Kim JW; Kim EY; Kim SY; Byun SK; Lee D; Oh KJ; Kim WK; Han BS; Chi SW; Lee SC; Bae KH
Mol Cells; 2014 Oct; 37(10):742-6. PubMed ID: 25266702
[TBL] [Abstract][Full Text] [Related]
5. A Flow Cytometry-based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer.
Nakhjavani M; Giles B; Strom M; Vi C; Attenborough S; Shigdar S
J Vis Exp; 2022 Sep; (187):. PubMed ID: 36190297
[TBL] [Abstract][Full Text] [Related]
6. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
7. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
Ji K; Lim WS; Li SF; Bhakoo K
Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
[TBL] [Abstract][Full Text] [Related]
8. Selection of DNA aptamers against epithelial cell adhesion molecule for cancer cell imaging and circulating tumor cell capture.
Song Y; Zhu Z; An Y; Zhang W; Zhang H; Liu D; Yu C; Duan W; Yang CJ
Anal Chem; 2013 Apr; 85(8):4141-9. PubMed ID: 23480100
[TBL] [Abstract][Full Text] [Related]
9. In silico design and validation of high-affinity RNA aptamers targeting epithelial cellular adhesion molecule dimers.
Bell DR; Weber JK; Yin W; Huynh T; Duan W; Zhou R
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8486-8493. PubMed ID: 32234785
[TBL] [Abstract][Full Text] [Related]
10. In silico designed RNA aptamer against epithelial cell adhesion molecule for cancer cell imaging.
Bavi R; Liu Z; Han Z; Zhang H; Gu Y
Biochem Biophys Res Commun; 2019 Feb; 509(4):937-942. PubMed ID: 30648555
[TBL] [Abstract][Full Text] [Related]
11. Anti-VCAM-1 and Anti-IL4Rα Aptamer-Conjugated Super Paramagnetic Iron Oxide Nanoparticles for Enhanced Breast Cancer Diagnosis and Therapy.
Chinnappan R; Al Faraj A; Abdel Rahman AM; Abu-Salah KM; Mouffouk F; Zourob M
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751068
[TBL] [Abstract][Full Text] [Related]
12. De Novo Evolution of an Antibody-Mimicking Multivalent Aptamer via a DNA Framework.
Tang L; Huang M; Zhang M; Pei Y; Liu Y; Wei Y; Yang C; Xie T; Zhang D; Zhou R; Song Y; Song J
Small Methods; 2023 Jun; 7(6):e2300327. PubMed ID: 37086150
[TBL] [Abstract][Full Text] [Related]
13. Aptamer-conjugated gold nanoparticles for bioanalysis.
Zhang J; Liu B; Liu H; Zhang X; Tan W
Nanomedicine (Lond); 2013 Jun; 8(6):983-93. PubMed ID: 23730697
[TBL] [Abstract][Full Text] [Related]
14. Selection of DNA aptamer against prostate specific antigen using a genetic algorithm and application to sensing.
Savory N; Abe K; Sode K; Ikebukuro K
Biosens Bioelectron; 2010 Dec; 26(4):1386-91. PubMed ID: 20692149
[TBL] [Abstract][Full Text] [Related]
15. EpCAM-Targeting Aptamer Radiotracer for Tumor-Specific PET Imaging.
Li F; Zeng Z; Hamilton D; Zu Y; Li Z
Bioconjug Chem; 2021 Jun; 32(6):1139-1145. PubMed ID: 34014641
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.
Wang J; Gao T; Luo Y; Wang Z; Zhang Y; Zhang Y; Zhang Y; Pei R
J Mol Evol; 2019 Apr; 87(2-3):72-82. PubMed ID: 30659315
[TBL] [Abstract][Full Text] [Related]
17. Development of DNA aptamers specific for small therapeutic peptides using a modified SELEX method.
Lee J; Ryu M; Bae D; Kim HM; Eyun SI; Bae J; Lee K
J Microbiol; 2022 Jul; 60(7):659-667. PubMed ID: 35731347
[TBL] [Abstract][Full Text] [Related]
18. Identification of liver cancer-specific aptamers using whole live cells.
Shangguan D; Meng L; Cao ZC; Xiao Z; Fang X; Li Y; Cardona D; Witek RP; Liu C; Tan W
Anal Chem; 2008 Feb; 80(3):721-8. PubMed ID: 18177018
[TBL] [Abstract][Full Text] [Related]
19. Aptamer selection and applications for breast cancer diagnostics and therapy.
Liu M; Yu X; Chen Z; Yang T; Yang D; Liu Q; Du K; Li B; Wang Z; Li S; Deng Y; He N
J Nanobiotechnology; 2017 Nov; 15(1):81. PubMed ID: 29132385
[TBL] [Abstract][Full Text] [Related]
20. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
